In the perspective of “real world-whole life”, the consortium will integrate multi-dimensional T3cDM clinical data, build high-precision prediction models, and develop intelligent decision support systems (DSS), to break through the technical bottleneck of individualized management, and realize the transformation from “experience driven” to “data driven”.
Adopting a “real-world, life-course” perspective, Track-T3c integrates multimodal clinical data—including longitudinal phenotypic, imaging, omics, and behavioral information—to build high-accuracy predictive models and deploy intelligent clinical decision support systems. This approach addresses critical bottlenecks in personalized management and facilitates a paradigm shift from experience-based to data-informed clinical practice.
By transcending disciplinary boundaries, the Consortium has established a comprehensive clinical prevention, treatment, and scientific research system across 16 provinces, cities, and autonomous regions nationwide, thereby forming a nationally representative diagnostic and therapeutic network for type 3c diabetes mellitus (T3cDM). In collaboration with leading universities and research institutes in Europe and the United States, we will systematically integrate epidemiological and clinical insights derived from the Chinese population to develop a diagnosis and treatment pathway that is scientifically sound, clinically applicable, and aligned with China’s healthcare context.
President, the International Pancreas Society (IPA)
President, the American Pancreas Association (APA)
President, the Southern California Hepatology Consortium
Emeritus tenured professor, University of California, Los Angeles
Chief, Gastroenterology at Cedars-Sinai Medical Center, USA
Director, Center of the Pancreatic Basic and Translational Medicine Research
The First National Excellent Young Physician
Medical Ph.D., Germany
Postdoctoral, University of California, USA
Member of Standing Committee, Chinese Society of Endocrinology
Director, Institute of Pancreatic Research, Southeast University
Director assistant, Zhongda Hospital, Southeast University
Academician of the Chinese Academy of Sciences
President, Chinese Society of Interventionalists
Director, National Comprehensive Interventional Technology Quality Control Center
Director, Medical Basic Research Innovation Center, Ministry of Education
Director, Department of Medicine and Life Sciences, Southeast University
Director, Interventional Therapy Center, Zhongda Hospital Affiliated to Southeast University
In the perspective of “real world-whole life”, the consortium will integrate multi-dimensional T3cDM clinical data, build high-precision prediction models, and develop intelligent decision support systems (DSS), to break through the technical bottleneck of individualized management, and realize the transformation from “experience driven” to “data driven”.
Adopting a “real-world, life-course” perspective, Track-T3c integrates multimodal clinical data—including longitudinal phenotypic, imaging, omics, and behavioral information—to build high-accuracy predictive models and deploy intelligent clinical decision support systems. This approach addresses critical bottlenecks in personalized management and facilitates a paradigm shift from experience-based to data-informed clinical practice.
By transcending disciplinary boundaries, the Consortium has established a comprehensive clinical prevention, treatment, and scientific research system across 16 provinces, cities, and autonomous regions nationwide, thereby forming a nationally representative diagnostic and therapeutic network for type 3c diabetes mellitus (T3cDM). In collaboration with leading universities and research institutes in Europe and the United States, we will systematically integrate epidemiological and clinical insights derived from the Chinese population to develop a diagnosis and treatment pathway that is scientifically sound, clinically applicable, and aligned with China’s healthcare context.
President, the International Pancreas Society (IPA)
President, the American Pancreas Association (APA)
President, the Southern California Hepatology Consortium
Emeritus tenured professor, University of California, Los Angeles
Chief, Gastroenterology at Cedars-Sinai Medical Center, USA
Director, Center of the Pancreatic Basic and Translational Medicine Research
The First National Excellent Young Physician
Medical Ph.D., Germany
Postdoctoral, University of California, USA
Member of Standing Committee, Chinese Society of Endocrinology
Director, Institute of Pancreatic Research, Southeast University
Director assistant, Zhongda Hospital, Southeast University
Academician of the Chinese Academy of Sciences
President, Chinese Society of Interventionalists
Director, National Comprehensive Interventional Technology Quality Control Center
Director, Medical Basic Research Innovation Center, Ministry of Education
Director, Department of Medicine and Life Sciences, Southeast University
Director, Interventional Therapy Center, Zhongda Hospital Affiliated to Southeast University
